Literature DB >> 17996989

Vaccination responses and lymphocyte subsets after autologous stem cell transplantation.

A M T van der Velden1, A M E Claessen, H van Velzen-Blad, M R de Groot, M H H Kramer, D H Biesma, G T Rijkers.   

Abstract

Twenty autologous stem cell transplant recipients were vaccinated with three doses of Diphtheria-Tetanus-Poliomyelitis vaccine and conjugated Haemophilus influenzae type b (Hib) vaccine. Pneumococcal vaccination consisted of two doses of conjugated vaccine followed by a single dose of polysaccharide vaccine, at 6, 8 and 14 months after transplantation, respectively. Mean anti-tetanus, anti-Hib and anti-pneumococcal IgG antibodies significantly increased after each vaccination. Response rates after the full vaccination schedule were 94%, 78% and 61% for Hib, conjugated 7-valent pneumococcal vaccine and non-conjugated 23-valent pneumococcal vaccine, respectively. Three months after transplantation, CD16(+)CD56(+) NK cells were in the normal range and remained so. The total number of T lymphocytes at 3 months was and remained in the normal range. The mean CD4/CD8 ratio was 0.43 at 3 months post aSCT and, while gradually increasing, remained subnormal. The mean number of CD19(+) B lymphocytes significantly increased during the study period. Patients with CD19 counts <0.10 x 10(9)L(-1) required at least two Hib vaccinations to show a response, while the majority of patients with CD19 counts > or = 0.20 x 10(9)L(-1) showed a response to Hib after one vaccination only. Thus, a minimum threshold level of CD19(+) cells appears to be required for adequate responses to vaccination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996989     DOI: 10.1016/j.vaccine.2007.10.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.

Authors:  Yvonne Suessmuth; Rithun Mukherjee; Benjamin Watkins; Divya T Koura; Knut Finstermeier; Cindy Desmarais; Linda Stempora; John T Horan; Amelia Langston; Muna Qayed; Hanna J Khoury; Audrey Grizzle; Jennifer A Cheeseman; Jason A Conger; Jennifer Robertson; Aneesah Garrett; Allan D Kirk; Edmund K Waller; Bruce R Blazar; Aneesh K Mehta; Harlan S Robins; Leslie S Kean
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

2.  Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

Authors:  Meighan Palazzo; Gunjan L Shah; Olivia Copelan; Kenneth Seier; Sean M Devlin; Molly Maloy; Sheila Kenny; Hani Hassoun; Neha S Korde; Nikoletta Lendvai; Alexander M Lesokhin; Sham Mailankody; David J Chung; Guenther Koehne; C Ola Landgren; Heather Landau; Sergio A Giralt; Miguel-Angel Perales
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-27       Impact factor: 5.742

Review 3.  Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures.

Authors:  Rupa R Patel; Stephen Y Liang; Pooja Koolwal; Frederick Matthew Kuhlmann
Journal:  Ther Clin Risk Manag       Date:  2015-02-12       Impact factor: 2.423

Review 4.  Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Authors:  C T Rieger; B Liss; S Mellinghoff; D Buchheidt; O A Cornely; G Egerer; W J Heinz; M Hentrich; G Maschmeyer; K Mayer; M Sandherr; G Silling; A Ullmann; M J G T Vehreschild; M von Lilienfeld-Toal; H H Wolf; N Lehners
Journal:  Ann Oncol       Date:  2018-06-01       Impact factor: 32.976

Review 5.  Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.

Authors:  Marta Morawska
Journal:  Eur J Haematol       Date:  2021-12-05       Impact factor: 3.674

Review 6.  Vaccine Responses in Adult Hematopoietic Stem Cell Transplant Recipients: A Comprehensive Review.

Authors:  Michelle Janssen; Anke Bruns; Jürgen Kuball; Reinier Raijmakers; Debbie van Baarle
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

7. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.